| Trial registration number
|
NCT05217771 |
Full text link
Last imported at : Feb. 2, 2022, 1 p.m.
Source : ClinicalTrials.gov
|
https://clinicaltrials.gov/show/NCT05217771
|
First author
Last imported at : Feb. 2, 2022, 1 p.m.
Source : ClinicalTrials.gov
|
Not reported
|
Contact
Last imported at : Feb. 2, 2022, 1 p.m.
Source : ClinicalTrials.gov
|
Not reported
|
Registration date
Last imported at : Feb. 2, 2022, 1 p.m.
Source : ClinicalTrials.gov
|
2022-02-01
|
Recruitment status
Last imported at : Feb. 2, 2022, 1 p.m.
Source : ClinicalTrials.gov
|
Not recruiting
|
Study design
Last imported at : Feb. 2, 2022, 1 p.m.
Source : ClinicalTrials.gov
|
RCT
|
Allocation
Last imported at : Feb. 2, 2022, 1 p.m.
Source : ClinicalTrials.gov
|
Randomized
|
Design
Last imported at : Feb. 2, 2022, 1 p.m.
Source : ClinicalTrials.gov
|
Parallel
|
Masking
Last imported at : Feb. 2, 2022, 1 p.m.
Source : ClinicalTrials.gov
|
Blind label
|
Center
Last imported at : Feb. 2, 2022, 1 p.m.
Source : ClinicalTrials.gov
|
single-center
|
Study aim
Last imported at : Feb. 2, 2022, 1 p.m.
Source : ClinicalTrials.gov
|
Long covid
|
Inclusion criteria
Last imported at : Feb. 2, 2022, 1 p.m.
Source : ClinicalTrials.gov
|
inclusion criteria:
all patients were diagnosed with covid-19 by polymerase chain reaction (pcr) test of a nasopharyngeal sample during acute phase, completed cbc, lymphocyte inflammatory marker, c-reactive protein and esr.
patients must be negative polymerase chain reaction (pcr).
patients will be completely recovered from acute symptoms of covid-19.
patients will be recruited after 2- 4 weeks post complete recovery from acute symptoms
|
Exclusion criteria
Last imported at : Feb. 2, 2022, 1 p.m.
Source : ClinicalTrials.gov
|
• patients with feverish systemic or local bacterial infections.
epilepsy.
pregnant women patients.
cancer.
uncontrolled diabetes milletus >250 mg/dl
|
Number of arms
Last imported at : Feb. 2, 2022, 1 p.m.
Source : ClinicalTrials.gov
|
2
|
Funding
Last imported at : Feb. 2, 2022, 1 p.m.
Source : ClinicalTrials.gov
|
October 6 University
|
Inclusion age min
Last imported at : Feb. 2, 2022, 1 p.m.
Source : ClinicalTrials.gov
|
40
|
Inclusion age max
Last imported at : Feb. 2, 2022, 1 p.m.
Source : ClinicalTrials.gov
|
60
|
Countries
Last imported at : Feb. 2, 2022, 1 p.m.
Source : ClinicalTrials.gov
|
Egypt
|
Type of patients
Last imported at : Feb. 2, 2022, 1 p.m.
Source : ClinicalTrials.gov
|
Patients recovered from covid
|
Severity scale
Last imported at : Feb. 2, 2022, 1 p.m.
Source : ClinicalTrials.gov
|
N/A
|
Total sample size
Last imported at : Feb. 2, 2022, 1 p.m.
Source : ClinicalTrials.gov
|
56
|
primary outcome
Last imported at : Feb. 2, 2022, 1 p.m.
Source : ClinicalTrials.gov
|
Chalder Fatigue Scale: score can range from 0 to 33, with a higher score indicating greater fatigue.;Six-Minute Walk Test
|
Notes
Last imported at : Feb. 2, 2022, 1 p.m.
Source : ClinicalTrials.gov
|
None
|
Phase
Last imported at : Feb. 2, 2022, 1 p.m.
Source : ClinicalTrials.gov
|
Not reported
|
Arms
Last imported at : Feb. 2, 2022, 1 p.m.
Source : ClinicalTrials.gov
|
[{"arm_notes": "", "treatment_id": 2359, "treatment_name": "High tone power therapy", "treatment_type": "Rehabilitation", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]
|